-
Mashup Score: 3In Refractory IBD, Combination Tx Appears Safe, Effective - 2 month(s) ago
In the treatment of IBD, combinations of biologics or a biologic and tofacitinib appeared to be generally safe and effective, according to a new systematic review and meta-analysis.
Source: www.medscape.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 5Tenapanor Shows Response in IBS-C Within Weeks - 3 month(s) ago
A post hoc analysis of three clinical trials shows the drug works within weeks to improve bowel function and abdominal symptoms in people with IBS-C.
Source: www.medscape.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 7The Microbiome: It's What's Inside That Counts - 3 month(s) ago
The microbiome is the constellation of microscopic organisms that call the human body home, and its clinical implications are becoming increasingly clear to physicians.
Source: www.medscape.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 9Artificial Sweeteners Alter the Duodenal Microbiome - 3 month(s) ago
Nonsugar sweeteners affected the stool and small bowel microbiomes differently, and the type of sweetener consumed proved relevant to which microbiome changes occurred.
Source: www.medscape.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 8Artificial Sweeteners Alter the Duodenal Microbiome - 3 month(s) ago
Nonsugar sweeteners affected the stool and small bowel microbiomes differently, and the type of sweetener consumed proved relevant to which microbiome changes occurred.
Source: www.medscape.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 11Artificial Sweeteners Alter the Duodenal Microbiome - 4 month(s) ago
Nonsugar sweeteners affected the stool and small bowel microbiomes differently, and the type of sweetener consumed proved relevant to which microbiome changes occurred.
Source: www.medscape.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 10Histologic Activity in IBD Ups Risk of Serious Infections - 5 month(s) ago
Histologic inflammation in IBD emerged as an independent risk factor for serious infection in a large Swedish population-based study.
Source: www.medscape.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 2GLP-1 RAs: How to Manage Real-World GI Complications - 5 month(s) ago
Although GLP-1 receptor agonists are transforming the treatment of diabetes and obesity, gastroenterologists increasingly are being called upon to manage the side effects of these medications.
Source: www.medscape.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0AGA publishes CPU for AI in colon polyp diagnosis and management - 5 month(s) ago
“We predict an AI suite of tools for colonoscopy will seem indispensable, as a powerful adjunct to support safe and efficient clinical practice,” write CPU authors.
Source: www.mdedge.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 5GLP-1 RAs: How to Manage Real-World GI Complications - 5 month(s) ago
Although GLP-1 receptor agonists are transforming the treatment of diabetes and obesity, gastroenterologists increasingly are being called upon to manage the side effects of these medications.
Source: www.medscape.comCategories: General Medicine News, General HCPsTweet
In the treatment of IBD, combinations of biologics or a biologic and tofacitinib appear to be generally safe and effective, according to a new systematic review and meta-analysis. #GastroTwitter https://t.co/whkf3yTVck https://t.co/bDy9EeW7Cw